Literature DB >> 11782537

Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1).

Donald Metcalf1, Sandra Mifsud, Ladina Di Rago, Nicos A Nicola, Douglas J Hilton, Warren S Alexander.   

Abstract

Mice with inactivation of the gene encoding the suppressor of cytokine signaling-1 (SOCS-1) die in neonatal life with an IFN-gamma-dependent inflammatory disease dominated by fatty degeneration and necrosis of the liver. To establish the long-term pathological consequences of loss of SOCS-1 in mice, where initial survival was made possible by also deleting the IFN-gamma gene, a comparison was made of the lifespan of groups of SOCS-1(-/-) IFN-gamma(-/-), SOCS-1(+/+) IFN-gamma(-/-) and SOCS-1(+/+) IFN-gamma(+/+) mice. Mice lacking the genes for both SOCS-1 and IFN-gamma exhibited an accelerated death rate compared with control groups. Disease states developing selectively in SOCS-1(-/-) IFN-gamma(-/-) mice were polycystic kidneys, pneumonia, chronic skin ulcers, and chronic granulomas in the gut and various other organs. Mice of all three groups developed cataracts, but disease development was accelerated in the groups lacking IFN-gamma. SOCS-1(-/-) IFN-gamma(-/-) mice exhibited a slightly increased predisposition to the development of T lymphoid leukemia, either spontaneous or radiation-induced. The development of polycystic kidneys may be caused by a developmental defect in renal-tubule organization noted in neonatal SOCS-1(-/-) mice. The chronic infections and granulomas of SOCS-1(-/-) IFN-gamma(-/-) mice may be based on autoaggression of SOCS-1(-/-) T lymphoid and related cells or a functional deficiency of these cells when lacking SOCS-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782537      PMCID: PMC117410          DOI: 10.1073/pnas.022628499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation.

Authors:  J G Zhang; A Farley; S E Nicholson; T A Willson; L M Zugaro; R J Simpson; R L Moritz; D Cary; R Richardson; G Hausmann; B T Kile; B J Kile; S B Kent; W S Alexander; D Metcalf; D J Hilton; N A Nicola; M Baca
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

2.  Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling.

Authors:  A Pezet; H Favre; P A Kelly; M Edery
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

3.  The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families.

Authors:  T Kamura; S Sato; D Haque; L Liu; W G Kaelin; R C Conaway; J W Conaway
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

4.  Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice.

Authors:  T Naka; T Matsumoto; M Narazaki; M Fujimoto; Y Morita; Y Ohsawa; H Saito; T Nagasawa; Y Uchiyama; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

5.  SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

Authors:  W S Alexander; R Starr; J E Fenner; C L Scott; E Handman; N S Sprigg; J E Corbin; A L Cornish; R Darwiche; C M Owczarek; T W Kay; N A Nicola; P J Hertzog; D Metcalf; D J Hilton
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

6.  SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality.

Authors:  J C Marine; D J Topham; C McKay; D Wang; E Parganas; D Stravopodis; A Yoshimura; J N Ihle
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

7.  Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins.

Authors:  J A Hansen; K Lindberg; D J Hilton; J H Nielsen; N Billestrup
Journal:  Mol Endocrinol       Date:  1999-11

Review 8.  Lens biology: development and human cataractogenesis.

Authors:  P J Francis; V Berry; A T Moore; S Bhattacharya
Journal:  Trends Genet       Date:  1999-05       Impact factor: 11.639

9.  Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation.

Authors:  P De Sepulveda; K Okkenhaug; J L Rose; R G Hawley; P Dubreuil; R Rottapel
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

10.  Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction.

Authors:  J A Losman; X P Chen; D Hilton; P Rothman
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

View more
  24 in total

Review 1.  Synergistic and feedback signaling mechanisms in the regulation of inflammation in respiratory infections.

Authors:  Wenzhuo Y Wang; Jae Hyang Lim; Jian-Dong Li
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

Review 2.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 3.  Suppressors of cytokine signaling in health and disease.

Authors:  Jane C Tan; Ralph Rabkin
Journal:  Pediatr Nephrol       Date:  2005-02-19       Impact factor: 3.714

Review 4.  Negative regulation of cytokine signaling.

Authors:  Akihiko Yoshimura
Journal:  Clin Rev Allergy Immunol       Date:  2005-06       Impact factor: 8.667

Review 5.  Strategies targeting cAMP signaling in the treatment of polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

Review 6.  Drug discovery for polycystic kidney disease.

Authors:  Ying Sun; Hong Zhou; Bao-xue Yang
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

7.  SOCS proteins in development and disease.

Authors:  Monique C Trengove; Alister C Ward
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

8.  SOCS5 is expressed in primary B and T lymphoid cells but is dispensable for lymphocyte production and function.

Authors:  Christine Brender; Ruth Columbus; Donald Metcalf; Emanuela Handman; Robyn Starr; Nick Huntington; David Tarlinton; Niels Ødum; Sandra E Nicholson; Nicos A Nicola; Douglas J Hilton; Warren S Alexander
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

9.  Differential expression and potential role of SOCS1 and SOCS3 in Wallerian degeneration in injured peripheral nerve.

Authors:  Elizabeth I Girolami; Delphine Bouhy; Michael Haber; Howard Johnson; Samuel David
Journal:  Exp Neurol       Date:  2009-07-02       Impact factor: 5.330

10.  Suppressor of cytokine signaling 1 blocks mitosis in human melanoma cells.

Authors:  Verónica Parrillas; Laura Martínez-Muñoz; Borja L Holgado; Amit Kumar; Graciela Cascio; Pilar Lucas; José Miguel Rodríguez-Frade; Marcos Malumbres; Ana C Carrera; Karel Hm van Wely; Mario Mellado
Journal:  Cell Mol Life Sci       Date:  2012-09-23       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.